{"id":"NCT02500706","sponsor":"Novo Nordisk A/S","briefTitle":"Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes","officialTitle":"Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-05-04","primaryCompletion":"2017-07-17","completion":"2017-08-16","firstPosted":"2015-07-16","resultsPosted":"2018-08-10","lastUpdate":"2019-06-12"},"enrollment":1108,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 1"],"interventions":[{"type":"DRUG","name":"Faster-acting insulin aspart","otherNames":[]},{"type":"DRUG","name":"insulin aspart","otherNames":[]},{"type":"DRUG","name":"insulin degludec","otherNames":[]}],"arms":[{"label":"Mealtime faster-acting insulin aspart and insulin degludec","type":"EXPERIMENTAL"},{"label":"Mealtime NovoRapid® and insulin degludec","type":"ACTIVE_COMPARATOR"},{"label":"Postmeal faster-acting insulin aspart and insulin degludec","type":"EXPERIMENTAL"}],"summary":"This trial is conducted in Asia, Europe and North America. The purpose is to confirm efficacy in terms of glycaemic control of treatment with mealtime faster-acting insulin aspart in combination with insulin degludec in adults with Type 1 Diabetes Mellitus.","primaryOutcome":{"measure":"Change From Baseline in HbA1c 26 Weeks After Randomisation","timeFrame":"Week 0, week 26","effectByArm":[{"arm":"Faster Aspart (Meal)","deltaMin":-0.12,"sd":0.64},{"arm":"Faster Aspart (Post)","deltaMin":0.005,"sd":0.64},{"arm":"NovoRapid (Meal)","deltaMin":-0.09,"sd":0.65}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG001 vs OG002","p":"<0.001"},{"comp":"OG000 vs OG002","p":"0.633"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":152,"countries":["United States","Austria","Bulgaria","Canada","Germany","India","Israel","Italy","Japan","Puerto Rico","Russia","Serbia","Taiwan"]},"refs":{"pmids":["30949906","30259644"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":20,"n":342},"commonTop":["Viral upper respiratory tract infection","Blood glucose decreased","Upper respiratory tract infection","Influenza"]}}